Search
for
Sort by
Research 871–900 of 1000+
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Nonclassic Congenital Adrenal Hyperplasia
- Modulatory role of vitamins A, B3, C, D, and E on skin health, immunity, microbiome, and diseases
- Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome
- Metabolomic biomarkers in women with polycystic ovary syndrome: a pilot study
- Hirsutism: Diagnosis and management
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Evaluation of affective temperament and anxiety–depression levels of patients with polycystic ovary syndrome
- Period problems: disorders of menstruation in adolescents
- Polycystic ovary syndrome is associated with anogenital distance, a marker of prenatal androgen exposure
- Androgen treatment of postmenopausal women
- Skin disease in pregnancy
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Deciphering principles of morphogenesis from temporal and spatial patterns on the integument
- Study on the zona pellucida 4 (ZP4) gene sequence and its expression in the ovaries of patients with polycystic ovary syndrome
- Hair follicles and their role in skin health
- Male fertility and skin diseases
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Androgens and hair: a biological paradox
- Treatment of hyperandrogenism in women
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- Hyperandrogenism in a Postmenopausal Woman Secondary to Testosterone Secreting Ovarian Stromal Tumor with Acoustic Schwannoma
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Hyperandrogenism in Women: Polycystic Ovary Syndrome
- Study of effect of myoinositol on menstrual irregularities and skin problems in polycystic ovarian syndrome cases
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
- Hair Disorders
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables